Infection surveillance solution is used to track antibiotic overdose or underuse and infection pattern, which aids hospitals and medical professionals to take timely precautions. It can be easily integrated with existing networks of hospitals and medical facilities.
The global infection surveillance solutions market is estimated to account for US$ 409.9 Mn in terms of value by the end of 2019.
Global Infection Surveillance Solutions Market: Drivers
Launch of advanced solutions is expected to propel growth of the global infection surveillance solutions market over the forecast period. For instance, in August 2020, Wolters Kluwer N.V. announced that its Sentri7 clinical surveillance solution has been enhanced with artificial intelligence (AI) to identify patients at risk for Clostridioides difficile (C. diff) infection.
Global Infection Surveillance Solutions Market: Opportunities
Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global infection surveillance solutions market. For instance, in October 2020, TestBoston study, a partnership between Brigham, the Broad Institute of MIT and Harvard and the MGB Center for COVID Innovation, was launched to increase coronavirus testing and surveillance in Boston, U.S.
Global Infection Surveillance Solutions Market: Restraints
Shortage of skilled staff is expected to hinder growth of the global infection surveillance solutions market. Increasing trend of migration of healthcare staff on international level, lack of appropriate training, and decreasing number of education programs for employees, results in shortage of skilled and experience healthcare staff and teams for using infection surveillance systems in healthcare settings
The global infection surveillance solutions market was valued at US$ 409.9 Mn in 2019 and is forecast to reach a value of US$ 1,177.7 Mn by 2027 at a CAGR of 13.9% between 2020 and 2027. Launch of advanced solutions is expected to propel growth of the global infection surveillance solutions market over the forecast period.
Software segment held dominant position in the global infection surveillance solutions market in 2019, accounting for 65.7% share in terms of value, increasing prevalence of infectious diseases along with technological advancement is anticipated to propel the segment growth during the forecast period.
To know the latest trends and insights prevalent in the Global Amitriptyline Market, click the link below:
Increasing adoption of infection surveillance solutions is expected to aid in growth of the market. For instance, in October 2018, the South Sudan Ministry of Health with support from the World Health Organization announced to establish sentinel surveillance for rotavirus infection in Juba in order to determine the extent of Rota virus infections among children and reduce child morbidity and mortality due to rotavirus infection.
Infection surveillance can be effective in containing infections in newborns. For instance, in 2018, a study by Drexel University reported that frequent MRSA surveillance could contain infection in newborns.
European Center for Disease Prevention and Control (ECDC)
European Academics Science Advisory Council (EASAC)
Global Infection Surveillance Solutions Market: Competitive Landscape
Major players operating in the global infection surveillance solutions market include, Becton Dickson & Company, Baxter International Inc., Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., Wolters Kluwer N.V., Vigilanz Corporation, Atlas Medical Software (Rpoer Technologies), RLDatix, and Quantros, Inc.
Global Infection Surveillance Solutions Market: Key Developments
Major players in the global infection surveillance solutions market are focused launching new products to enhance their market share. For instance, in May 2020, VigiLanz Corporation launched COVID Quick Start – a new solution that will enable hospitals to prepare for, prevent, and respond to the spread of COVID-19 and other respiratory viral illnesses.
Scope of the report